FDA.reportPublic FDA data

cutaquig 16.5 % (4 GM in 24 ML) Injection

RxCUI
2167163
RxNorm name
cutaquig 16.5 % (4 GM in 24 ML) Injection
Display name
cutaquig 16.5 % (4 GM in 24 ML) Injection
Full name
cutaquig 16.5 % (4 GM in 24 ML) Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125668CutaquigImmune Globulin Subcutaneous (Human)-hipp351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f199187a-de4e-2047-0aee-b6d93390b3d2cutaquig 16.5 % (4 GM in 24 ML) Injection [PSN] · 24 ML immune globulin subcutaneous (human) - hipp 165 MG/ML Injection [Cutaquig] [SBD] · 24 ML Cutaquig 165 MG/ML Injection [SY] · cutaquig 16.5 % (4 GM per 24 ML) Injection [SY]415These highlights do not include all the information needed to use CUTAQUIG safely and effectively. See full prescribing information for CUTAQUIG. CUTAQUIG® (Immune Globulin Subcutaneous (Human) - hipp), 16.5% solution Initial U.S. Approval: 201820250324
f3de095f-791a-85dc-7a14-ec7790cb13aacutaquig 16.5 % (4 GM in 24 ML) Injection [PSN] · 24 ML immune globulin subcutaneous (human) - hipp 165 MG/ML Injection [Cutaquig] [SBD] · 24 ML Cutaquig 165 MG/ML Injection [SY] · cutaquig 16.5 % (4 GM per 24 ML) Injection [SY]413These highlights do not include all the information needed to use CUTAQUIG safely and effectively. See full prescribing information for CUTAQUIG. CUTAQUIG® (Immune Globulin Subcutaneous (Human) - hipp), 16.5% solution Initial U.S. Approval: 201820211130